90 related articles for article (PubMed ID: 26530747)
1. Assessment of Parametrial Response by Growth Pattern in Patients With International Federation of Gynecology and Obstetrics Stage IIB and IIIB Cervical Cancer: Analysis of Patients From a Prospective, Multicenter Trial (EMBRACE).
Yoshida K; Jastaniyah N; Sturdza A; Lindegaard J; Segedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz I; Haie-Meder C; Sasaki R; Pötter R
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):788-96. PubMed ID: 26530747
[TBL] [Abstract][Full Text] [Related]
2. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study.
Pötter R; Tanderup K; Schmid MP; Jürgenliemk-Schulz I; Haie-Meder C; Fokdal LU; Sturdza AE; Hoskin P; Mahantshetty U; Segedin B; Bruheim K; Huang F; Rai B; Cooper R; van der Steen-Banasik E; Van Limbergen E; Pieters BR; Tan LT; Nout RA; De Leeuw AAC; Ristl R; Petric P; Nesvacil N; Kirchheiner K; Kirisits C; Lindegaard JC;
Lancet Oncol; 2021 Apr; 22(4):538-547. PubMed ID: 33794207
[TBL] [Abstract][Full Text] [Related]
3. Carbon ion radiotherapy for mesonephric adenocarcinoma of the uterine cervix: a case report.
Kobayashi N; Oike T; Ando K; Murata K; Tamaki T; Noda SE; Kogure K; Nobusawa S; Oyama T; Ohno T
J Med Case Rep; 2024 May; 18(1):228. PubMed ID: 38720351
[TBL] [Abstract][Full Text] [Related]
4. Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging - An analysis from the EMBRACE study.
Knoth J; Pötter R; Jürgenliemk-Schulz IM; Haie-Meder C; Fokdal L; Sturdza A; Hoskin P; Mahantshetty U; Segedin B; Bruheim K; Wiebe E; Rai B; Cooper R; van der Steen-Banasik E; van Limbergen E; Pieters BR; Sundset M; Tan LT; Nout RA; Tanderup K; Kirisits C; Nesvacil N; Lindegaard JC; Schmid MP
Gynecol Oncol; 2020 Oct; 159(1):136-141. PubMed ID: 32798000
[TBL] [Abstract][Full Text] [Related]
5. Local Control and Use of External Beam Parametrial Boost in the Era of Image-Guided Brachytherapy for Locally Advanced Cervical Cancer.
Arya R; Giurcanu M; Jutzy JM; Peters P; Daily EW; Golden DW; McCall AR; Howard AR; Hasan Y; Son CH
Am J Clin Oncol; 2021 Nov; 44(11):565-571. PubMed ID: 34456239
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of the value of pre- and post-treatment magnetic resonance imaging examinations for advanced cervical cancer.
Csutak C; Ordeanu C; Nagy VM; Pop DC; Bolboaca SD; Badea R; Chiorean L; Dudea SM
Clujul Med; 2016; 89(3):410-8. PubMed ID: 27547062
[TBL] [Abstract][Full Text] [Related]
7. Rationality of FIGO 2018 IIIC restaging of cervical cancer according to local tumor size: A cohort study.
Duan H; Li H; Kang S; Zhao H; Chen B; Wang L; Li P; Wang Y; Wang W; Lang J; Liu P; Chen C
Acta Obstet Gynecol Scand; 2023 Aug; 102(8):1045-1052. PubMed ID: 37338046
[TBL] [Abstract][Full Text] [Related]
8. The prognostic effect of tumor volume, reduction ratio, and cumulative doses on external beam radiotherapy with central-shielding method and image-guided adaptive brachytherapy for cervical cancer.
Ohtaka T; Ando K; Oike T; Noda SE; Kaminuma T; Murata K; Ohno T
Front Oncol; 2024; 14():1366777. PubMed ID: 38774419
[TBL] [Abstract][Full Text] [Related]
9. Occult invasive cervical cancer, FIGO stage III, with a negative Pap smear test - clinical presentation and brief review of the literature.
Meloni P; Simari T; Roberta L; Cassella I; Brizio R; Conturso R; Russo D; Araujo Júnior E; Tonni G
Ceska Gynekol; 2024; 89(1):34-39. PubMed ID: 38418251
[TBL] [Abstract][Full Text] [Related]
10. The value of MRI in quantification of parametrial invasion and association with prognosis in locally advanced cervical cancer: the "PLACE" study.
Russo L; Pasciuto T; Lupinelli M; Urbano A; D'Erme L; Amerighi A; Fanfani F; Scambia G; Manfredi R; Sala E; Ferrandina G; Gui B
Eur Radiol; 2023 Nov; ():. PubMed ID: 37981591
[TBL] [Abstract][Full Text] [Related]
11. Tumor Staging of Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists.
Park KJ; Roma A; Singh N; Gilks CB; Oliva E; Abu-Rustum N; Ramirez PT; McCluggage WG
Int J Gynecol Pathol; 2021 Mar; 40(Suppl 1):S92-S101. PubMed ID: 33570866
[TBL] [Abstract][Full Text] [Related]
12. Updated Trends in Cervical Cancer Brachytherapy Utilization and Disparities in the United States From 2004 to 2020.
Colson-Fearon D; Han K; Roumeliotis MB; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2024 May; 119(1):154-162. PubMed ID: 38040060
[TBL] [Abstract][Full Text] [Related]
13. Improving Global Outcomes in Cervical Cancer: The Time Has Come for International Federation of Gynecology and Obstetrics Staging to Formally Incorporate Advanced Imaging.
Jolly S; Uppal S; Bhatla N; Johnston C; Maturen K
J Glob Oncol; 2018 Sep; 4():1-6. PubMed ID: 30241155
[No Abstract] [Full Text] [Related]
14. Utility of CT Scan in Detecting Bladder Involvement Among Patients With Cervical Carcinoma.
Agrawal R; Agarwal R
Cureus; 2024 Feb; 16(2):e53670. PubMed ID: 38455819
[TBL] [Abstract][Full Text] [Related]
15. Temporal analysis of tumor heterogeneity and volume for cervical cancer treatment outcome prediction: preliminary evaluation.
Prescott JW; Zhang D; Wang JZ; Mayr NA; Yuh WT; Saltz J; Gurcan M
J Digit Imaging; 2010 Jun; 23(3):342-57. PubMed ID: 19172357
[TBL] [Abstract][Full Text] [Related]
16. A Dire Presentation of Carcinoma Cervix in a Human Immunodeficiency Virus-Positive Case: A Salient Display.
Pamnani S; Bakshi SS; Chakole S
Cureus; 2023 Sep; 15(9):e45605. PubMed ID: 37868493
[TBL] [Abstract][Full Text] [Related]
17. [USE OF THE CRYOSTAT IN OBSTETRICS AND GYNECOLOGY].
MISONOU T
Sanfujinka Chiryo; 1963 Dec; 7():629-37. PubMed ID: 14100346
[No Abstract] [Full Text] [Related]
18. A volumetric analysis of GTV
Jastaniyah N; Yoshida K; Tanderup K; Lindegaard JC; Sturdza A; Kirisits C; Šegedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz IM; Haie-Meder C; Banerjee S; Pötter R;
Radiother Oncol; 2016 Sep; 120(3):404-411. PubMed ID: 27452409
[TBL] [Abstract][Full Text] [Related]
19. Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study.
Mazeron R; Fokdal LU; Kirchheiner K; Georg P; Jastaniyah N; Šegedin B; Mahantshetty U; Hoskin P; Jürgenliemk-Schulz I; Kirisits C; Lindegaard JC; Dörr W; Haie-Meder C; Tanderup K; Pötter R;
Radiother Oncol; 2016 Sep; 120(3):412-419. PubMed ID: 27396811
[TBL] [Abstract][Full Text] [Related]
20. Health-Related Quality of Life in Locally Advanced Cervical Cancer Patients After Definitive Chemoradiation Therapy Including Image Guided Adaptive Brachytherapy: An Analysis From the EMBRACE Study.
Kirchheiner K; Pötter R; Tanderup K; Lindegaard JC; Haie-Meder C; Petrič P; Mahantshetty U; Jürgenliemk-Schulz IM; Rai B; Cooper R; Dörr W; Nout RA;
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1088-98. PubMed ID: 26876955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
